Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma.
Truini A, Coco S, Nadal E, Genova C, Mora M, Dal Bello MG, Vanni I, Alama A, Rijavec E, Biello F, Barletta G, Merlo DF, Valentino A, Ferro P, Ravetti GL, Stigliani S, Vigani A, Fedeli F, Beer DG, Roncella S, Grossi F. Truini A, et al. Among authors: roncella s. Oncotarget. 2017 Aug 2;8(40):68627-68640. doi: 10.18632/oncotarget.19800. eCollection 2017 Sep 15. Oncotarget. 2017. PMID: 28978143 Free PMC article.
CTLA-4 in mesothelioma patients: tissue expression, body fluid levels and possible relevance as a prognostic factor.
Roncella S, Laurent S, Fontana V, Ferro P, Franceschini MC, Salvi S, Varesano S, Boccardo S, Vigani A, Morabito A, Canessa PA, Giannoni U, Rosenberg I, Valentino A, Fedeli F, Merlo DF, Ceppi M, Riggio S, Romani M, Saverino D, Poggi A, Pistillo MP. Roncella S, et al. Cancer Immunol Immunother. 2016 Aug;65(8):909-17. doi: 10.1007/s00262-016-1844-3. Epub 2016 May 20. Cancer Immunol Immunother. 2016. PMID: 27207606
Amplification of MET in a Patient with Malignant Pleural Mesothelioma.
Varesano S, Salvi S, Boccardo S, Ravetti JL, Ferro P, Canessa PA, Fedeli F, Pistillo MP, Roncella S. Varesano S, et al. Among authors: roncella s. J Thorac Oncol. 2015 Oct;10(10):e103-4. doi: 10.1097/JTO.0000000000000638. J Thorac Oncol. 2015. PMID: 26398828 Free article. No abstract available.
Use of Serum Mesothelin as an Indicator of Tumor Progression in Routine Clinical Practice of Malignant Pleural Mesothelioma Treatment.
Vigani A, Pistillo MP, Fontana V, Giannoni U, Rosenberg I, Canessa PA, Berisso G, Ferro P, Franceschini MC, Tonarelli M, Roncella S. Vigani A, et al. Among authors: roncella s. J Thorac Oncol. 2018 Aug;13(8):e143-e145. doi: 10.1016/j.jtho.2018.03.015. J Thorac Oncol. 2018. PMID: 30049376 Free article. No abstract available.
91 results